Editas Medicine, Inc. EDIT
Nov 11, 2026, 11:31 AM EST
- YTD
- +20.24%
- 1 year
- -7.33%
EDIT free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-165,579,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | -165,579,000 | 53,531,000 | Not meaningful |
| FY 2024 | 2024-12-31 | -219,110,000 | -82,213,000 | Not meaningful |
| FY 2023 | 2023-12-31 | -136,897,000 | 44,552,000 | Not meaningful |
| FY 2022 | 2022-12-31 | -181,449,000 | -9,669,000 | Not meaningful |
| FY 2021 | 2021-12-31 | -171,780,000 | 15,213,000 | Not meaningful |
| FY 2020 | 2020-12-31 | -186,993,000 | -140,259,000 | Not meaningful |
| FY 2019 | 2019-12-31 | -46,734,000 | 3,690,000 | Not meaningful |
| FY 2018 | 2018-12-31 | -50,424,000 | -38,963,000 | Not meaningful |
| FY 2017 | 2017-12-31 | -11,461,000 | 42,258,000 | Not meaningful |
| FY 2016 | 2016-12-31 | -53,719,000 | -46,845,000 | Not meaningful |
| FY 2015 | 2015-12-31 | -6,874,000 | 2,998,000 | Not meaningful |
| FY 2014 | 2014-12-31 | -9,872,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-11T07:00:37.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.